Dr. Reena Rupani, MD

Dr. Rupani practices at Bislr Medical Groups Of Mount Sinai in New York, New York.

Dr. Rupani's NPI, 1457576530, was assigned on April 16, 2007. Dr. Rupani graduated from Yale University School of Medicine in 2004. Dr. Rupani holds New York license 247927.

Dr. Rupani's primary practice is Bislr Medical Groups of Mount Sinai, at 309 W 23rd St Fl 3 Fl 3, New York, NY 10011. The practice phone is (212) 352-2600.

Dr. Rupani's primary practice is Bislr Medical Groups Of Mount Sinai in New York, New York. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Rupani to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rupani practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rupani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rupani is licensed in New York.

CMS data shows 1,274 Medicare services from Dr. Rupani across 9 procedure codes in 2024, for 316 Medicare patients. Medicare paid $84,141 for them. Every service was in an office.

CMS counts 316 Medicare patients who saw Dr. Rupani in 2024. The largest group is 65 to 74, with 173 patients. 72% of them have high cholesterol, and 53% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rupani's median patient age at 54, with 62% women.

In 2024, Dr. Rupani wrote 560 Medicare Part D claims for 177 patients. 87% of them were for generic drugs. CMS names the drug for 414 of them, across 16 drugs with 11 or more claims each, at $24,699 in total drug cost. In 2023, CMS named 279 claims across 9 drugs.

Dr. Rupani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rupani as offering telehealth. CMS counts 432 procedures of removal of skin lesions by Dr. Rupani, more than 85% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Rupani, published from 2013 to 2019. 2018 was the busiest year, with 2. The most frequent topics are Phytotherapy and Psoriasis. Dr. Rupani has published most often in J Drugs Dermatol. Dr. Rupani's most frequent co-authors are Cody Jerome Connor, MD, Boni E. Elewski and Craig A. Elmets, MD.

CMS Open Payments shows 13 general payments to Dr. Rupani from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $490.

Dr. Rupani graduated from Yale University School of Medicine in 2004.